vimarsana.com

Page 352 - ஒன்றுபட்டது மாநிலங்களில் பத்திரங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

With Recent Advancements, North America Is Expected To Dominate Psychedelic Drugs Market

With Recent Advancements, North America Is Expected To Dominate Psychedelic Drugs Market Financialnewsmedia.com News Commentary Share this article Share this article PALM BEACH, Fla., March 9, 2021 /PRNewswire/  The time of Tune In… Turn On… and Dropout psychedelics, such as certain, mushrooms and of course, LSD were not only not legal, but no researcher could even suggest studying the compounds… they were universally declared taboo. My, but how times have changed now that the baby boomers are old and want treatments for what life is bringing them now… new, effective treatments. Psychedelic medicine is one of the fastest growing markets. Psychedelic Medicines also called as hallucinogenics, are a group of substances including chemicals, such as LSD, and plants that are used in the treatment of various mental disorders such as resistant depression, panic disorder, opiate addiction, etc. These are used to change and enhance sensory perceptions, energy levels, thought pr

International Business Machines Corp - Doc re Form DEF 14A

International Business Machines Corp - Doc re Form DEF 14A PR Newswire TIDM IBM The Corporation s Notice of 2021 Annual Meeting and Proxy Statement on Form DEF 14A dated March 8, 2021 was filed with the United States Securities and Exchange Commission and subsequently in Luxembourg with the Luxembourg Stock Exchange as the officially appointed mechanism for the central storage of regulated information and with the CSSF. The report is available at www.sec.gov and www.bourse.lu. common stock as of December 31, 2020. The DEF 14A filing contains information as to certain persons who have publicly disclosed that they are the beneficial owners of

NanoViricides, Inc Pan-coronavirus COVID-19 Drug Candidates Are Highly Effective in Pre-clinical Animal Studies in Support of FDA Pre-IND Application

(2) SHELTON, CT / ACCESSWIRE / March 9, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the Company ), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reported today on the strong effectiveness of its two COVID-19 clinical drug candidates in an animal model of coronavirus infection. The Company is preparing a pre-IND application encompassing its two clinical drug candidates for the treatment of COVID-19 infected patients. Of these, NV-CoV-2 is the Company s broad-spectrum anti-coronavirus drug candidate based on its nanoviricides® platform that is expected to be capable of attacking most, if not all, SARS-CoV-2 variants and other coronaviruses. In addition, the Company is also developing NV-CoV-2-R that combines (1) the power of NV-CoV-2 to attack and potentially dismantle the virus particles outside cells, and (2) the power of remdesivir to block further production of virus particles inside cells. Blocking the com

American Aires Inc : American Aires Engages Consulting Firm for Hiring Chief Revenue Officer

American Aires Inc.: American Aires Engages Consulting Firm for Hiring Chief Revenue Officer Toronto, Ontario (Newsfile Corp. - March 9, 2021) - American Aires Inc. (CSE: WIFI) (the Company or Aires ) is pleased to announce that it has engaged the firm of Berglass Associates, a Management and Consulting Firm, to assist the Company in hiring a Chief Revenue Officer (CRO) who will provide the wealth of experience and global marketing expertise required to bring Aires to the next level of marketing and sales success. Berglass Associates is a firm based out of New York with a reputation for connecting companies with best-of-breed talent in whatever role a company requires. Aires search for a high quality, experienced and forward looking individual to take charge of the CRO position of the Company is intended to facilitate the most expedient journey on the path toward increased profits and Company growth.

First Trust Global Portfolios Limited: First Trust Global Portfolios Management Limited Announces Distributions for certain sub-funds of First Trust Global Funds plc

First Trust Global Portfolios Limited: First Trust Global Portfolios Management Limited Announces Distributions for certain sub-funds of First Trust Global Funds plc ISIN UCITS ETF Class B Quarterly Quarterly UCITS ETF Class B Quarterly Quarterly The Funds are advised by First Trust Advisors L.P. ( FTA ). The following dates apply to today s distribution declaration: Expected Ex-Dividend Date: About First Trust Advisors L.P. FTA is a privately owned US-based financial services firm and is registered as an investment adviser with the United States Securities and Exchange Commission. FTA acts as adviser to a range of Irish domiciled UCITS funds under the First Trust Global Funds plc umbrella. The Funds distributors are FTGPM and First Trust Global Portfolios Limited ( FT UK ), an affiliate of FTA. FTGPM is the management company of First Trust Global Funds plc umbrella. FT UK was established in December 2011 as a UK-based and UK Financial Conduct Authority (

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.